Cargando…
Metformin inhibits tumor growth by regulating multiple miRNAs in human cholangiocarcinoma
The antidiabetic drug metformin exerts antineoplastic effects in many types of malignancies, however the effect of metformin on cholangiocarcinoma (CCA) still remains unclear. In the present study, we investigated that metformin treatment was closely associated with the clinicopathologic characteris...
Autores principales: | Jiang, Xingming, Ma, Ning, Wang, Dayong, Li, Fuyuan, He, Rongzhang, Li, Dongliang, Zhao, Ruiqi, Zhou, Qingxin, Wang, Yimin, Zhang, Fumin, Wan, Ming, Kang, Pengcheng, Gao, Xu, Cui, Yunfu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4413646/ https://www.ncbi.nlm.nih.gov/pubmed/25605008 |
Ejemplares similares
-
NcRNAs and Cholangiocarcinoma
por: Wangyang, Zheng, et al.
Publicado: (2018) -
The prognostic potential and carcinogenesis of long non-coding RNA TUG1 in human cholangiocarcinoma
por: Xu, Yi, et al.
Publicado: (2017) -
Retraction: The prognostic potential and carcinogenesis of long non-coding RNA TUG1 in human cholangiocarcinoma
por: Xu, Yi, et al.
Publicado: (2023) -
The Prognostic Role of SOCS3 and A20 in Human Cholangiocarcinoma
por: Wang, Yimin, et al.
Publicado: (2015) -
Long non-coding RNA NNT-AS1 functions as an oncogenic gene through modulating miR-485/BCL9 in cholangiocarcinoma
por: Huang, Lining, et al.
Publicado: (2019)